Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

2(28.6%)

Phase 1

1(14.3%)

7Total

N/A(4)

Phase 4(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07554820Phase 4Recruiting

Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

Role: lead

NCT07544888Phase 1Completed

Effectiveness of Valsartan Alone vs Combination Therapy in Hypertensive Heart Disease

Role: lead

NCT07517627Not ApplicableRecruiting

Optimal Timings of Laparoscopic Cholecystectomy After ERCP in Patients With Gallstones Along With CBD Stones

Role: collaborator

NCT07160452Phase 4Not Yet Recruiting

Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia

Role: lead

NCT07149480Not ApplicableCompleted

Comparison of Postoperative Outcomes of Interlay vs Underlay Graft in Tympanoplasty

Role: lead

NCT07016919Not ApplicableRecruiting

Early vs Conventional Enteral Nutrition After Uncomplicated Paediatric Open Appendectomy

Role: lead

NCT06260241Not ApplicableRecruiting

Gain in Stretched Penile Length After Phalloplasty With & Without Penile Traction in Children.

Role: lead

All 7 trials loaded